JAYME CHAPADOS: Open Payments
NPI 1790206969 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 64 payments from 17 companies in 2025. Trend: 2023 $1,751 · 2024 $1,634 · 2025 $1,463
Food & beverage: $1,371Education: $92
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $359 |
| GENZYME CORPORATION | 16 | $240 |
| ABBVIE INC. | 6 | $174 |
| Regeneron Healthcare Solutions, Inc. | 8 | $161 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $55 |
| Janssen Biotech, Inc. | 2 | $53 |
| Botanix SB Inc | 2 | $40 |
| Blueprint Medicines Corporation | 1 | $34 |
Products named: DUPIXENT, SKYRIZI, AYVAKIT, COSENTYX, Sotyktu, TREMFYA, SOFDRA, Rhapsido.
Industry payments across TX — which companies pay providers there.
